Abstract
We estimated the mean serial interval and superspreading potential for the Delta variant SARS-CoV-2. As the Delta variant increased in prevalence, the mean serial interval declined from 4.0 to 2.5 days. However, the risk of superspreading events was similar, as 25% to 27% of cases seeded 80% of all transmissions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Basic Science Research Program through the National Research Foundation of Korea, funded by the Korean Ministry of Education (NRF-2020R1I1A3066471).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was conducted using the publicly available data so that IRB was not necessary.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data is available upon reasonable request to the corresponding author.
